Changes in regional brain volumes in social anxiety disorder following 12 weeks of treatment with escitalopram

Metabolic Brain Disease

Volumn 25, Issue 4, 2010, Pages 369-374

  Cassimjee, Naseema ^a   Fouche, Jean Pierre ^a   Burnett, Michael ^a   Lochner, Christine ^a   Warwick, James ^a   Dupont, Patrick ^b   Stein, Dan J ^a,c   Cloete, Karen J ^a   Carey, Paul D ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Escitalopram; Regional brain volumes; Social anxiety disorder; Structural magnetic resonance imaging

Indexed keywords

ESCITALOPRAM;

ADULT; AGED; ARTICLE; BRAIN SIZE; CEREBELLUM VERMIS; CLINICAL ARTICLE; FEMALE; GRAY MATTER; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SOCIAL PHOBIA; TEMPORAL CORTEX; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANXIETY; ANXIETY DISORDERS; BRAIN; CITALOPRAM; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FRONTAL LOBE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; TEMPORAL LOBE; YOUNG ADULT;

EID: 78751598185     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-010-9218-6     Document Type: Article

References (35)

1. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th ed Text Revision (DSMIV-TR). American Psychiatric Publishing, Washington DC
2. B Aouizerate C Martin-Guehl J Tignol 2004 Neurobiology and pharmacotherapy of social phobia Encephale 30 301 313 1:STN:280: DC%2BD2crmsFyltQ%3D%3D 10.1016/S0013-7006(04)95442-5 15538306
3. JD Bremner E Vermetten 2004 Neuroanatomical changes associated with pharmacotherapy in posttraumatic stress disorder Ann NY Acad Sci 1032 154 157 10.1196/annals.1314.012 15677402 (Pubitemid 40298467)
4. JD Bremner M Vythilingam E Vermetten SM Southwick T McGlashan A Nazeer S Khan V Vaccarino R Soufer PK Garg CK Ng LH Staib JS Duncan DS Charney 2003 MRI and PET study of deficits in hippocampal structure and function in women with childhood sexual abuse and posttraumatic stress disorder Am J Psychiatry 160 924 932 10.1176/appi.ajp.160.5.924 12727697 (Pubitemid 41079578)
5. S Campbell G MacQueen 2006 An update on regional brain volume differences associated with mood disorders Curr Opin Psychiatry 19 25 33 10.1097/01.yco.0000194371.47685.f2 16612175 (Pubitemid 44406141)
6. E Castrén T Rantamäki 2008 Neurotrophins in depression and antidepressant effects Novartis Found Symp 289 43 52 10.1002/9780470751251.ch4 18497094
7. CH Chen K Ridler J Suckling S Williams CH Fu E Merlo-Pich E Bullmore 2007 Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment Biol Psychiatry 62 407 414 1:CAS:528:DC%2BD2sXpsFGlsrk%3D 10.1016/j.biopsych.2006.09.018 17217921 (Pubitemid 47284016)
8. G Chételat B Landeau F Eustache F Mézenge F Viader V De La Sayette B Desgranges JC Baron 2005 Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study Neuroimage 27 934 946 10.1016/j.neuroimage.2005.05.015 15979341 (Pubitemid 41317262)
9. K Engel B Bandelow O Gruber D Wedekind 2009 Neuroimaging in anxiety disorders J Neural Transm 116 703 716 10.1007/s00702-008-0077-9 18568288
10. P Fossati A Radtchenko P Boyer 2004 Neuroplasticity: from MRI to depressive symptoms Eur Neuropsychopharmacol 14 S503 S510 1:CAS:528: DC%2BD2cXhtVSktrjP 10.1016/j.euroneuro.2004.09.001 15550349 (Pubitemid 39531612)
11. MC Freitas-Ferrari JEC Hallak C Trzesniak AS Filho JP Machado-de-Sousa MHN Chagas AE Nardi JAS Crippa 2010 Neuroimaging in social anxiety disorder: a systematic review of the literature Prog Neuropsychopharmacol Biol Psychiatry 34 565 580 10.1016/j.pnpbp.2010.02.028 20206659
12. T Frodl C Schule G Schmitt C Born T Baghai P Zill R Bottlender R Rupprecht B Bondy M Reiser HJ Möller EM Meisenzahl 2007 Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression Arch Gen Psychiatry 64 410 416 1:CAS:528: DC%2BD2sXltlWisrs%3D 10.1001/archpsyc.64.4.410 17404118 (Pubitemid 46556460)
13. T Furmark M Tillfors I Marteinsdottir H Fischer A Pissiota B Långström M Fredrikson 2002 Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy Arch Gen Psychiatry 59 425 433 10.1001/archpsyc.59.5.425 11982446
14. T Furmark L Appel A Michelgård K Wahlstedt F Ahs S Zancan E Jacobsson K Flyckt M Grohp M Bergström EM Pich LG Nilsson M Bani B Långström M Fredrikson 2005 Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo Biol Psychiatry 58 132 142 1:CAS:528:DC%2BD2MXmsVWrs7Y%3D 10.1016/j.biopsych.2005.03.029 16038684 (Pubitemid 41008130)
15. CD Good IS Johnsrude J Ashburner RN Henson KJ Friston RS Frackowiak 2001 A voxel-based morphometric study of ageing in 465 normal adult human brains Neuroimage 14 21 36 1:STN:280:DC%2BD3MvotFCntg%3D%3D 10.1006/nimg.2001.0786 11525331 (Pubitemid 32552740)
16. Guy W (1976) ECDU assessment manual for psychopharmacology. National Institute of Mental Health, Research Branch, pp 313-331
17. JC Ipser CM Kariuki DJ Stein 2008 Pharmacotherapy for social anxiety disorder: a systematic review Expert Rev Neurother 8 235 257 1:CAS:528:DC%2BD1cXhvVylsLc%3D 10.1586/14737175.8.2.235 18271710 (Pubitemid 351281112)
18. CD Kilts JE Kelsey B Knight TD Ely FD Bowman RE Gross A Selvig A Gordon DJ Newport CB Nemeroff 2006 The neural correlates of social anxiety disorder and response to pharmacotherapy Neuropsychopharmacol 3 2243 2253
19. UE Lang MC Jockers-Scherubl R Hellweg 2004 State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations J Neural Transm 111 387 411 1:STN:280:DC%2BD2c7gtV2htw%3D%3D 10.1007/s00702-003- 0100-0 14991461 (Pubitemid 38316612)
20. HN Levinson 1989 A cerebellar-vestibular explanation for fears/phobias: hypothesis and study Percept Mot Skills 68 67 84 1:STN:280:DyaL1M7otlGiug%3D%3D 2928069
21. HN Levinson 1989 The cerebellar-vestibular predisposition to anxiety disorders Percept Mot Skills 68 323 338 1:STN:280:DyaL1M7otlGisQ%3D%3D 2928066
22. MR Liebowitz 1987 Social phobia Mod Probl Pharmacopsychiatry 22 141 173 1:STN:280:DyaL2s3lsl2msg%3D%3D 2885745
23. JP Lorberbaum S Kose MR Johnson GW Arana LK Sullivan MB Hamner JC Ballenger RB Lydiard PS Brodrick DE Bohning MS George 2004 Neural correlates of speech anticipatory anxiety in generalized social phobia NeuroReport 15 2701 2705 15597038
24. K Martinowich H Manji B Lu 2007 New insights into BDNF function in depression and anxiety Nat Neurosci 10 1089 1093 1:CAS:528:DC%2BD2sXps1Sgu7g%3D 10.1038/nn1971 17726474 (Pubitemid 47339961)
25. SA Montgomery M Asberg 1979 A new depression scale designed to be sensitive to change Br J Psychiatry 134 382 389 1:STN:280:DyaE1M7ovVCksg%3D%3D 10.1192/bjp.134.4.382 444788
26. Nass R (2002) Plasticity: mechanisms, extent and limits. In: Segalowitz SJ, Rapin I (eds) Handbook of neuropsychology, 2nd ed, vol 8(1), Child neuropsychology, part 1. Elsevier, Amsterdam, pp 29-68
27. T Rantamäki P Hendolin A Kankaanpää J Mijatovic P Piepponen E Domenici MV Chao PT Männistö E Castrén 2007 Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain Neuropsychopharmacol 32 2152 2162 10.1038/sj.npp.1301345 (Pubitemid 47417694)
28. AF Schinder M Poo 2000 The neurotrophin hypothesis for synaptic plasticity Trends Neurosci 23 639 645 1:CAS:528:DC%2BD3MXhsVymtw%3D%3D 10.1016/S0166-2236(00)01672-6 11137155 (Pubitemid 32007891)
29. DV Sheehan Y Lecrubier KH Sheehan P Amorim J Janavs E Weiller T Hergueta R Baker GC Dunbar 1998 The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 59 22 33 9881538
30. M Spedding P Gressens 2008 Neurotrophins and cytokines in neuronal plasticity Novartis Found Symp 289 222 233 1:CAS:528:DC%2BD1cXps1Kjurc%3D 10.1002/9780470751251.ch18 18497106
31. M Tillfors T Furmark I Marteinsdottir M Fredrikson 2002 Cerebral blood flow during anticipation of public speaking in social phobia: a PET study Biol Psychiatry 52 1113 1119 10.1016/S0006-3223(02)01396-3 12460694 (Pubitemid 35379968)
32. E Vermetten M Vythilingam SM Southwick DS Charney JD Bremner 2003 Long-term treatment with paroxetine increases verbal declarative memory and hippocampal volume in posttraumatic stress disorder Biol Psychiatry 54 693 702 1:CAS:528:DC%2BD3sXnsVKlsbo%3D 10.1016/S0006-3223(03)00634-6 14512209 (Pubitemid 37281385)
33. JFM Vetencourt A Sale A Viegi L Baroncelli R De Pasquale OF O'Leary E Castrén L Maffei 2008 The antidepressant fluoxetine restores plasticity in the adult visual cortex Science 320 385 388 10.1126/science.1150516 (Pubitemid 351555663)
34. JM Warwick P Carey G Van der Linden C Prinsloo D Niehaus S Seedat P Dupont DJ Stein 2006 A comparison of the effects of citalopram and moclobemide on resting brain perfusion in social anxiety disorder Metab Brain Dis 21 241 252 1:CAS:528:DC%2BD28XhtlantbnF 10.1007/s11011-006-9009-2 16850261
35. JM Warwick P Carey GP Jordaan P Dupont DJ Stein 2008 Resting brain perfusion in social anxiety disorder: a voxel-wise whole brain comparison with healthy control subjects Prog Neuropsychopharmacol Biol Psychiatry 32 1251 1256 1:STN:280:DC%2BD1czptVWhsA%3D%3D 10.1016/j.pnpbp.2008.03.017 18485554